| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 450 | 2024 | 8601 | 17.980 |
Why?
|
| tau Proteins | 134 | 2024 | 2095 | 17.380 |
Why?
|
| Plaque, Amyloid | 103 | 2024 | 760 | 11.920 |
Why?
|
| Neurofibrillary Tangles | 93 | 2024 | 457 | 11.590 |
Why?
|
| Amyloid beta-Peptides | 186 | 2024 | 3839 | 10.510 |
Why?
|
| Tauopathies | 36 | 2024 | 320 | 7.670 |
Why?
|
| Amyloid beta-Protein Precursor | 103 | 2020 | 1111 | 7.390 |
Why?
|
| Apolipoproteins E | 87 | 2024 | 1444 | 6.440 |
Why?
|
| Neurons | 172 | 2024 | 9463 | 5.830 |
Why?
|
| Brain | 245 | 2024 | 27120 | 5.270 |
Why?
|
| Mice, Transgenic | 146 | 2024 | 9541 | 4.060 |
Why?
|
| Astrocytes | 28 | 2024 | 1346 | 3.700 |
Why?
|
| Apolipoprotein E4 | 42 | 2024 | 709 | 3.260 |
Why?
|
| Amyloid | 31 | 2024 | 841 | 3.200 |
Why?
|
| alpha-Synuclein | 55 | 2023 | 750 | 3.070 |
Why?
|
| Microglia | 31 | 2024 | 1361 | 3.070 |
Why?
|
| Lewy Body Disease | 23 | 2024 | 252 | 3.010 |
Why?
|
| Presenilin-1 | 58 | 2021 | 660 | 2.720 |
Why?
|
| Apolipoprotein E2 | 11 | 2024 | 135 | 2.590 |
Why?
|
| Hippocampus | 77 | 2023 | 3766 | 2.570 |
Why?
|
| Nerve Tissue Proteins | 52 | 2024 | 4415 | 2.540 |
Why?
|
| Disease Models, Animal | 108 | 2024 | 18253 | 2.430 |
Why?
|
| Synapses | 32 | 2021 | 1769 | 2.320 |
Why?
|
| Neurites | 28 | 2015 | 391 | 2.210 |
Why?
|
| Endopeptidases | 23 | 2009 | 774 | 2.150 |
Why?
|
| Nerve Degeneration | 20 | 2020 | 748 | 2.120 |
Why?
|
| Mice | 252 | 2024 | 81533 | 2.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 23 | 2017 | 421 | 2.030 |
Why?
|
| Dendritic Spines | 12 | 2013 | 243 | 1.980 |
Why?
|
| Animals | 361 | 2024 | 168467 | 1.970 |
Why?
|
| Entorhinal Cortex | 15 | 2023 | 287 | 1.960 |
Why?
|
| Caspases | 11 | 2014 | 879 | 1.850 |
Why?
|
| Temporal Lobe | 31 | 2016 | 1695 | 1.730 |
Why?
|
| Peptide Fragments | 46 | 2021 | 5112 | 1.730 |
Why?
|
| Lewy Bodies | 20 | 2012 | 145 | 1.690 |
Why?
|
| Cerebral Cortex | 53 | 2024 | 5779 | 1.570 |
Why?
|
| Neurodegenerative Diseases | 19 | 2024 | 1088 | 1.500 |
Why?
|
| Aging | 55 | 2022 | 8711 | 1.470 |
Why?
|
| Aspartic Acid Endopeptidases | 23 | 2015 | 311 | 1.460 |
Why?
|
| Supranuclear Palsy, Progressive | 5 | 2024 | 81 | 1.380 |
Why?
|
| Amyloid Precursor Protein Secretases | 40 | 2021 | 620 | 1.360 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 16 | 2015 | 267 | 1.360 |
Why?
|
| Apolipoprotein E3 | 14 | 2022 | 107 | 1.350 |
Why?
|
| Membrane Proteins | 40 | 2011 | 7858 | 1.350 |
Why?
|
| Humans | 644 | 2024 | 761572 | 1.350 |
Why?
|
| Phosphorylation | 45 | 2024 | 8321 | 1.330 |
Why?
|
| Transfection | 46 | 2015 | 5774 | 1.290 |
Why?
|
| Receptors, LDL | 15 | 2011 | 488 | 1.290 |
Why?
|
| Microscopy, Fluorescence | 25 | 2013 | 2645 | 1.280 |
Why?
|
| Parkinson Disease | 35 | 2023 | 2877 | 1.280 |
Why?
|
| Neuronal Plasticity | 15 | 2021 | 1436 | 1.260 |
Why?
|
| Aged, 80 and over | 160 | 2024 | 58986 | 1.220 |
Why?
|
| Prions | 4 | 2024 | 180 | 1.220 |
Why?
|
| Visual Cortex | 7 | 2021 | 1108 | 1.200 |
Why?
|
| Antibodies | 11 | 2023 | 2418 | 1.140 |
Why?
|
| Immunohistochemistry | 75 | 2023 | 11076 | 1.110 |
Why?
|
| Dependovirus | 13 | 2021 | 718 | 1.090 |
Why?
|
| Dementia | 30 | 2022 | 2689 | 1.050 |
Why?
|
| Brain Chemistry | 18 | 2012 | 960 | 1.000 |
Why?
|
| Synaptophysin | 10 | 2020 | 139 | 0.980 |
Why?
|
| Substantia Nigra | 13 | 2013 | 350 | 0.980 |
Why?
|
| LDL-Receptor Related Proteins | 9 | 2024 | 118 | 0.980 |
Why?
|
| Cerebral Amyloid Angiopathy | 18 | 2023 | 895 | 0.970 |
Why?
|
| Calcineurin | 5 | 2019 | 229 | 0.970 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2020 | 174 | 0.970 |
Why?
|
| Aged | 251 | 2024 | 169310 | 0.960 |
Why?
|
| Protein Isoforms | 18 | 2022 | 1699 | 0.960 |
Why?
|
| Green Fluorescent Proteins | 30 | 2018 | 2065 | 0.960 |
Why?
|
| Receptors, Immunologic | 15 | 2017 | 1410 | 0.930 |
Why?
|
| RNA, Messenger | 41 | 2024 | 12794 | 0.920 |
Why?
|
| Synucleins | 22 | 2005 | 108 | 0.900 |
Why?
|
| Dominance, Ocular | 2 | 2021 | 30 | 0.890 |
Why?
|
| Disease Progression | 38 | 2024 | 13510 | 0.890 |
Why?
|
| Cells, Cultured | 70 | 2024 | 18965 | 0.880 |
Why?
|
| Inclusion Bodies | 13 | 2020 | 281 | 0.880 |
Why?
|
| Axons | 16 | 2024 | 1674 | 0.880 |
Why?
|
| Frontotemporal Dementia | 6 | 2024 | 247 | 0.850 |
Why?
|
| Cognition Disorders | 24 | 2020 | 3980 | 0.850 |
Why?
|
| Amyotrophic Lateral Sclerosis | 9 | 2024 | 1469 | 0.840 |
Why?
|
| Dendrites | 11 | 2012 | 475 | 0.830 |
Why?
|
| Neurofibrils | 12 | 2006 | 75 | 0.820 |
Why?
|
| Gliosis | 10 | 2024 | 245 | 0.810 |
Why?
|
| Receptors, Cell Surface | 12 | 2009 | 2822 | 0.810 |
Why?
|
| Proteasome Endopeptidase Complex | 10 | 2021 | 1321 | 0.800 |
Why?
|
| HSP70 Heat-Shock Proteins | 9 | 2015 | 397 | 0.790 |
Why?
|
| Vision, Ocular | 2 | 2017 | 455 | 0.780 |
Why?
|
| Blood-Brain Barrier | 7 | 2022 | 1027 | 0.770 |
Why?
|
| Protein Multimerization | 9 | 2016 | 983 | 0.770 |
Why?
|
| Ubiquitin | 5 | 2012 | 839 | 0.760 |
Why?
|
| Gene Expression Regulation | 26 | 2021 | 11904 | 0.740 |
Why?
|
| National Institute on Aging (U.S.) | 6 | 2024 | 39 | 0.730 |
Why?
|
| Molecular Chaperones | 10 | 2018 | 754 | 0.730 |
Why?
|
| Protein Structure, Tertiary | 31 | 2014 | 3792 | 0.720 |
Why?
|
| Male | 240 | 2024 | 360842 | 0.720 |
Why?
|
| Alternative Splicing | 7 | 2007 | 1093 | 0.720 |
Why?
|
| Protein Interaction Mapping | 5 | 2008 | 616 | 0.720 |
Why?
|
| Microscopy | 9 | 2016 | 903 | 0.720 |
Why?
|
| Biosensing Techniques | 2 | 2024 | 650 | 0.720 |
Why?
|
| Cell Nucleus | 12 | 2018 | 2910 | 0.710 |
Why?
|
| Mutation | 54 | 2024 | 30054 | 0.700 |
Why?
|
| Presynaptic Terminals | 5 | 2017 | 302 | 0.690 |
Why?
|
| Alleles | 37 | 2021 | 6864 | 0.690 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 27 | 2015 | 3810 | 0.670 |
Why?
|
| Enzyme Activation | 11 | 2014 | 3597 | 0.670 |
Why?
|
| Female | 227 | 2024 | 392686 | 0.660 |
Why?
|
| Polymorphism, Genetic | 16 | 2006 | 4243 | 0.660 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2024 | 4063 | 0.650 |
Why?
|
| Olfactory Pathways | 4 | 2017 | 132 | 0.650 |
Why?
|
| Microscopy, Confocal | 21 | 2017 | 1971 | 0.640 |
Why?
|
| Gene Expression | 24 | 2020 | 7581 | 0.640 |
Why?
|
| Down Syndrome | 8 | 2017 | 901 | 0.640 |
Why?
|
| HEK293 Cells | 13 | 2021 | 4280 | 0.640 |
Why?
|
| Protein Transport | 20 | 2024 | 1967 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 44 | 2021 | 22172 | 0.630 |
Why?
|
| Cricetinae | 29 | 2011 | 2423 | 0.620 |
Why?
|
| Protein Binding | 35 | 2024 | 9353 | 0.610 |
Why?
|
| Protein Processing, Post-Translational | 11 | 2024 | 1974 | 0.610 |
Why?
|
| Protein Structure, Quaternary | 7 | 2023 | 429 | 0.600 |
Why?
|
| Immunization, Passive | 4 | 2009 | 616 | 0.600 |
Why?
|
| Genetic Predisposition to Disease | 22 | 2021 | 17904 | 0.590 |
Why?
|
| CHO Cells | 24 | 2024 | 1387 | 0.590 |
Why?
|
| Carrier Proteins | 15 | 2011 | 4937 | 0.590 |
Why?
|
| Receptors, Lipoprotein | 6 | 2007 | 88 | 0.590 |
Why?
|
| Cytoplasm | 11 | 2021 | 1510 | 0.580 |
Why?
|
| Neurotoxins | 12 | 2006 | 240 | 0.580 |
Why?
|
| Blotting, Western | 23 | 2014 | 5035 | 0.580 |
Why?
|
| Carbolines | 5 | 2017 | 296 | 0.580 |
Why?
|
| Cytoskeletal Proteins | 5 | 2017 | 1342 | 0.570 |
Why?
|
| Genotype | 54 | 2021 | 12990 | 0.560 |
Why?
|
| Cell Death | 12 | 2024 | 1679 | 0.560 |
Why?
|
| Cricetulus | 15 | 2024 | 814 | 0.560 |
Why?
|
| Luciferases | 8 | 2011 | 714 | 0.560 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 539 | 0.560 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2015 | 305 | 0.560 |
Why?
|
| Cerebrovascular Circulation | 5 | 2023 | 2727 | 0.560 |
Why?
|
| Cell Count | 19 | 2013 | 1835 | 0.550 |
Why?
|
| Receptors, Chemokine | 6 | 2008 | 652 | 0.550 |
Why?
|
| Neocortex | 9 | 2017 | 417 | 0.540 |
Why?
|
| Protein Conformation | 19 | 2017 | 3968 | 0.540 |
Why?
|
| Transcription Factors | 10 | 2021 | 12129 | 0.540 |
Why?
|
| Apoptosis | 14 | 2014 | 9489 | 0.540 |
Why?
|
| NFATC Transcription Factors | 4 | 2018 | 389 | 0.530 |
Why?
|
| Cell Line | 39 | 2020 | 15601 | 0.530 |
Why?
|
| Nerve Net | 7 | 2018 | 2291 | 0.530 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 278 | 0.520 |
Why?
|
| Cell Membrane | 12 | 2018 | 3687 | 0.510 |
Why?
|
| Pick Disease of the Brain | 3 | 2024 | 42 | 0.510 |
Why?
|
| Subcellular Fractions | 7 | 2012 | 532 | 0.510 |
Why?
|
| Amyloidosis | 6 | 2019 | 817 | 0.510 |
Why?
|
| Smell | 2 | 2017 | 259 | 0.500 |
Why?
|
| Caspase 3 | 7 | 2017 | 731 | 0.500 |
Why?
|
| Thiazoles | 11 | 2015 | 1517 | 0.500 |
Why?
|
| In Situ Hybridization | 14 | 2020 | 1900 | 0.490 |
Why?
|
| ADP-Ribosylation Factors | 2 | 2006 | 133 | 0.490 |
Why?
|
| Protein Folding | 10 | 2017 | 870 | 0.490 |
Why?
|
| Glial Fibrillary Acidic Protein | 12 | 2020 | 553 | 0.490 |
Why?
|
| Age of Onset | 18 | 2020 | 3306 | 0.480 |
Why?
|
| Neural Pathways | 15 | 2014 | 3060 | 0.480 |
Why?
|
| Endocytosis | 13 | 2020 | 957 | 0.480 |
Why?
|
| Atrophy | 12 | 2024 | 1633 | 0.480 |
Why?
|
| Luminescent Proteins | 8 | 2014 | 837 | 0.470 |
Why?
|
| AIDS-Related Complex | 1 | 2014 | 107 | 0.470 |
Why?
|
| RNA Probes | 2 | 2014 | 111 | 0.470 |
Why?
|
| Calcium-Binding Proteins | 7 | 2018 | 1069 | 0.450 |
Why?
|
| Middle Aged | 138 | 2024 | 220920 | 0.440 |
Why?
|
| Neuroglia | 9 | 2023 | 956 | 0.440 |
Why?
|
| Methylene Blue | 1 | 2014 | 155 | 0.440 |
Why?
|
| Membrane Transport Proteins | 5 | 2024 | 1035 | 0.440 |
Why?
|
| Adaptor Proteins, Signal Transducing | 15 | 2017 | 2898 | 0.430 |
Why?
|
| Mitochondria | 10 | 2021 | 3624 | 0.430 |
Why?
|
| Visual Pathways | 1 | 2017 | 551 | 0.430 |
Why?
|
| Neuropsychological Tests | 22 | 2021 | 7054 | 0.430 |
Why?
|
| alpha-Macroglobulins | 6 | 2002 | 60 | 0.430 |
Why?
|
| Memory Disorders | 10 | 2016 | 1199 | 0.430 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2014 | 1651 | 0.420 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2024 | 100 | 0.420 |
Why?
|
| Corpus Striatum | 13 | 2024 | 1235 | 0.420 |
Why?
|
| Aptamers, Nucleotide | 1 | 2014 | 165 | 0.410 |
Why?
|
| Cerebrum | 1 | 2014 | 132 | 0.410 |
Why?
|
| Heterozygote | 4 | 2020 | 2787 | 0.410 |
Why?
|
| Recombinant Fusion Proteins | 13 | 2013 | 3733 | 0.400 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5869 | 0.400 |
Why?
|
| Nuclear Proteins | 9 | 2013 | 5799 | 0.400 |
Why?
|
| Cell Compartmentation | 4 | 2010 | 384 | 0.400 |
Why?
|
| Autopsy | 12 | 2019 | 1009 | 0.400 |
Why?
|
| Sensory Deprivation | 2 | 2012 | 108 | 0.400 |
Why?
|
| Macromolecular Substances | 8 | 2004 | 1434 | 0.390 |
Why?
|
| Benzothiazoles | 8 | 2018 | 247 | 0.390 |
Why?
|
| Cognition | 16 | 2022 | 6992 | 0.390 |
Why?
|
| Culture Media, Conditioned | 6 | 2018 | 522 | 0.390 |
Why?
|
| Introns | 6 | 2011 | 981 | 0.380 |
Why?
|
| Rats | 50 | 2022 | 23741 | 0.380 |
Why?
|
| Autoantibodies | 5 | 2016 | 2116 | 0.380 |
Why?
|
| Tubulin | 4 | 2017 | 693 | 0.380 |
Why?
|
| Immunoblotting | 9 | 2016 | 1646 | 0.380 |
Why?
|
| Axonal Transport | 2 | 2024 | 178 | 0.370 |
Why?
|
| Calcium Signaling | 6 | 2019 | 733 | 0.370 |
Why?
|
| Molecular Weight | 9 | 2018 | 2186 | 0.360 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 489 | 0.360 |
Why?
|
| Biopolymers | 1 | 2011 | 184 | 0.360 |
Why?
|
| Genetic Complementation Test | 1 | 2011 | 555 | 0.360 |
Why?
|
| Spectrometry, Fluorescence | 10 | 2005 | 685 | 0.350 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2014 | 857 | 0.350 |
Why?
|
| Preoperative Care | 3 | 2017 | 2242 | 0.350 |
Why?
|
| Synaptic Transmission | 3 | 2010 | 1173 | 0.350 |
Why?
|
| Tacrolimus | 2 | 2010 | 733 | 0.350 |
Why?
|
| Regeneration | 1 | 2019 | 1512 | 0.340 |
Why?
|
| Multifactorial Inheritance | 5 | 2019 | 1387 | 0.340 |
Why?
|
| Proteostasis Deficiencies | 2 | 2020 | 39 | 0.340 |
Why?
|
| Cell Survival | 12 | 2021 | 5791 | 0.340 |
Why?
|
| Immunoassay | 1 | 2013 | 745 | 0.340 |
Why?
|
| Positron-Emission Tomography | 16 | 2022 | 6485 | 0.330 |
Why?
|
| Point Mutation | 4 | 2004 | 1595 | 0.330 |
Why?
|
| Membrane Glycoproteins | 10 | 2017 | 3701 | 0.330 |
Why?
|
| Dopamine | 9 | 2009 | 1607 | 0.330 |
Why?
|
| Exons | 7 | 2022 | 2391 | 0.330 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 1860 | 0.330 |
Why?
|
| Chemokines, CXC | 2 | 2002 | 422 | 0.330 |
Why?
|
| Calcium | 11 | 2019 | 5722 | 0.330 |
Why?
|
| Genetic Vectors | 11 | 2018 | 3396 | 0.330 |
Why?
|
| Genome-Wide Association Study | 18 | 2024 | 12690 | 0.330 |
Why?
|
| Biophysical Phenomena | 5 | 2018 | 320 | 0.320 |
Why?
|
| Alkenes | 4 | 2008 | 54 | 0.320 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 271 | 0.320 |
Why?
|
| Neuropil | 5 | 2003 | 31 | 0.320 |
Why?
|
| Nervous System | 1 | 2012 | 545 | 0.320 |
Why?
|
| Huntington Disease | 4 | 2024 | 1144 | 0.310 |
Why?
|
| Homozygote | 6 | 2020 | 1776 | 0.310 |
Why?
|
| Lysosomes | 5 | 2012 | 924 | 0.310 |
Why?
|
| Ligands | 17 | 2020 | 3272 | 0.310 |
Why?
|
| Cell Line, Tumor | 27 | 2024 | 16986 | 0.310 |
Why?
|
| Animals, Genetically Modified | 5 | 2011 | 1561 | 0.310 |
Why?
|
| Neurosciences | 3 | 2019 | 367 | 0.310 |
Why?
|
| Frontotemporal Lobar Degeneration | 4 | 2015 | 102 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 7391 | 0.310 |
Why?
|
| Enzyme Inhibitors | 11 | 2013 | 3713 | 0.300 |
Why?
|
| Base Sequence | 24 | 2015 | 12441 | 0.300 |
Why?
|
| Endosomes | 5 | 2005 | 522 | 0.300 |
Why?
|
| Oxidative Stress | 11 | 2021 | 3113 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2024 | 36429 | 0.300 |
Why?
|
| Embryo, Mammalian | 11 | 2011 | 1674 | 0.300 |
Why?
|
| Drug Discovery | 2 | 2021 | 1051 | 0.300 |
Why?
|
| Fluorescent Dyes | 12 | 2014 | 1903 | 0.290 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2017 | 2748 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2014 | 8181 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 20 | 2017 | 9177 | 0.290 |
Why?
|
| Receptor, Notch1 | 9 | 2009 | 496 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 20 | 2017 | 9002 | 0.280 |
Why?
|
| Gene Expression Profiling | 11 | 2024 | 9420 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 1246 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 5 | 2021 | 1474 | 0.280 |
Why?
|
| Models, Neurological | 7 | 2020 | 1769 | 0.270 |
Why?
|
| Heat-Shock Proteins | 4 | 2008 | 795 | 0.270 |
Why?
|
| Synaptotagmin I | 2 | 2017 | 33 | 0.270 |
Why?
|
| Tyrosine | 5 | 2009 | 1440 | 0.270 |
Why?
|
| Tomography, Emission-Computed | 4 | 2003 | 1122 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2021 | 15936 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 6 | 2015 | 1899 | 0.260 |
Why?
|
| Chromatography, Gel | 4 | 2021 | 645 | 0.260 |
Why?
|
| Longitudinal Studies | 25 | 2021 | 14607 | 0.260 |
Why?
|
| Reference Values | 15 | 2013 | 4920 | 0.260 |
Why?
|
| Genes, Reporter | 7 | 2009 | 1529 | 0.260 |
Why?
|
| Staining and Labeling | 6 | 2023 | 1085 | 0.260 |
Why?
|
| Societies, Medical | 4 | 2013 | 3905 | 0.260 |
Why?
|
| Phosphotransferases | 2 | 1997 | 303 | 0.260 |
Why?
|
| Postmortem Changes | 5 | 2010 | 119 | 0.260 |
Why?
|
| Leucine | 4 | 2014 | 548 | 0.250 |
Why?
|
| Electron Transport Complex IV | 3 | 1995 | 190 | 0.250 |
Why?
|
| Neuroaxonal Dystrophies | 3 | 2008 | 26 | 0.250 |
Why?
|
| Glioma | 8 | 2009 | 3455 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 7 | 2009 | 895 | 0.250 |
Why?
|
| Golgi Apparatus | 5 | 2010 | 405 | 0.250 |
Why?
|
| Haplotypes | 6 | 2020 | 2713 | 0.240 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2019 | 793 | 0.240 |
Why?
|
| Binding, Competitive | 6 | 2005 | 1141 | 0.240 |
Why?
|
| Extracellular Space | 3 | 2010 | 563 | 0.240 |
Why?
|
| Caregivers | 3 | 2022 | 2238 | 0.240 |
Why?
|
| TYK2 Kinase | 1 | 2024 | 38 | 0.240 |
Why?
|
| Molecular Sequence Data | 26 | 2014 | 17635 | 0.240 |
Why?
|
| Subtraction Technique | 1 | 2008 | 512 | 0.240 |
Why?
|
| Serine | 5 | 2023 | 830 | 0.240 |
Why?
|
| Extracellular Fluid | 3 | 2016 | 165 | 0.240 |
Why?
|
| Transcription, Genetic | 6 | 2024 | 7593 | 0.240 |
Why?
|
| Fluorescence | 4 | 2012 | 756 | 0.240 |
Why?
|
| Quinones | 1 | 2004 | 78 | 0.240 |
Why?
|
| Case-Control Studies | 25 | 2020 | 22176 | 0.240 |
Why?
|
| Genetic Loci | 5 | 2021 | 2632 | 0.230 |
Why?
|
| Proline | 3 | 2024 | 457 | 0.230 |
Why?
|
| Phenotype | 16 | 2023 | 16592 | 0.230 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2002 | 58 | 0.230 |
Why?
|
| Population Surveillance | 1 | 2015 | 2598 | 0.230 |
Why?
|
| Cohort Studies | 28 | 2021 | 41493 | 0.230 |
Why?
|
| Dinoprost | 2 | 2003 | 138 | 0.230 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 1134 | 0.230 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2009 | 1693 | 0.230 |
Why?
|
| Olfactory Perception | 2 | 2016 | 65 | 0.230 |
Why?
|
| Ubiquitins | 3 | 2000 | 366 | 0.230 |
Why?
|
| Benzodiazepinones | 2 | 2013 | 50 | 0.220 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 1393 | 0.220 |
Why?
|
| Mental Status Schedule | 6 | 2016 | 315 | 0.220 |
Why?
|
| Solubility | 7 | 2012 | 1091 | 0.220 |
Why?
|
| Age Factors | 19 | 2017 | 18398 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 10 | 2011 | 6132 | 0.220 |
Why?
|
| Down-Regulation | 6 | 2009 | 2919 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2013 | 4575 | 0.220 |
Why?
|
| Transgenes | 7 | 2016 | 1010 | 0.220 |
Why?
|
| Alzheimer Vaccines | 1 | 2003 | 25 | 0.210 |
Why?
|
| Nitric Oxide Synthase | 5 | 1997 | 908 | 0.210 |
Why?
|
| Interneurons | 3 | 2024 | 593 | 0.210 |
Why?
|
| Recombinant Proteins | 8 | 2019 | 6534 | 0.210 |
Why?
|
| Injections, Intraventricular | 5 | 2021 | 225 | 0.210 |
Why?
|
| Aspartic Acid | 3 | 2009 | 576 | 0.210 |
Why?
|
| Nervous System Diseases | 6 | 2024 | 1667 | 0.210 |
Why?
|
| Energy Transfer | 5 | 2004 | 108 | 0.210 |
Why?
|
| Prion Diseases | 1 | 2024 | 100 | 0.210 |
Why?
|
| Macrophage Inflammatory Proteins | 3 | 2000 | 121 | 0.210 |
Why?
|
| Congo Red | 1 | 2002 | 48 | 0.210 |
Why?
|
| Olfactory Bulb | 4 | 2006 | 198 | 0.210 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1993 | 149 | 0.200 |
Why?
|
| Amnesia | 2 | 2011 | 257 | 0.200 |
Why?
|
| Striatonigral Degeneration | 1 | 2002 | 13 | 0.200 |
Why?
|
| Photic Stimulation | 3 | 2014 | 1987 | 0.200 |
Why?
|
| Biological Assay | 3 | 2018 | 626 | 0.200 |
Why?
|
| Geriatric Assessment | 4 | 2017 | 1410 | 0.200 |
Why?
|
| Transduction, Genetic | 4 | 2016 | 903 | 0.200 |
Why?
|
| Biotinylation | 5 | 2010 | 184 | 0.200 |
Why?
|
| Neuroprotective Agents | 4 | 2021 | 957 | 0.200 |
Why?
|
| Analysis of Variance | 9 | 2015 | 6228 | 0.200 |
Why?
|
| Benzene | 1 | 2002 | 106 | 0.200 |
Why?
|
| Severity of Illness Index | 16 | 2021 | 15843 | 0.200 |
Why?
|
| Tissue Distribution | 9 | 2012 | 2264 | 0.200 |
Why?
|
| Cholesterol | 7 | 2021 | 2904 | 0.200 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1206 | 0.200 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 550 | 0.190 |
Why?
|
| Time Factors | 25 | 2021 | 39970 | 0.190 |
Why?
|
| Histone Deacetylase 1 | 1 | 2022 | 133 | 0.190 |
Why?
|
| Central Nervous System | 3 | 2016 | 1336 | 0.190 |
Why?
|
| Dizocilpine Maleate | 5 | 2000 | 172 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2016 | 10766 | 0.190 |
Why?
|
| Cell Movement | 6 | 2016 | 5205 | 0.190 |
Why?
|
| Multiple System Atrophy | 1 | 2023 | 130 | 0.190 |
Why?
|
| Neuroblastoma | 5 | 2018 | 1250 | 0.190 |
Why?
|
| Trinucleotide Repeats | 2 | 2007 | 257 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2015 | 452 | 0.190 |
Why?
|
| Immunoprecipitation | 6 | 2012 | 878 | 0.190 |
Why?
|
| Photons | 6 | 2013 | 589 | 0.190 |
Why?
|
| Chemotactic Factors | 1 | 2002 | 197 | 0.190 |
Why?
|
| Oligopeptides | 4 | 2012 | 1187 | 0.190 |
Why?
|
| DNA, Complementary | 6 | 2012 | 1991 | 0.190 |
Why?
|
| Binding Sites | 13 | 2013 | 6056 | 0.190 |
Why?
|
| Receptors, GABA | 2 | 2022 | 313 | 0.190 |
Why?
|
| Acetyltransferases | 1 | 2002 | 231 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 13 | 2015 | 6075 | 0.180 |
Why?
|
| Clinical Trials as Topic | 7 | 2024 | 8002 | 0.180 |
Why?
|
| Aniline Compounds | 5 | 2015 | 1069 | 0.180 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 6 | 2010 | 427 | 0.180 |
Why?
|
| Sterilization | 1 | 2021 | 133 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2013 | 1435 | 0.180 |
Why?
|
| Signal Transduction | 13 | 2015 | 23447 | 0.180 |
Why?
|
| Antibody Specificity | 4 | 2017 | 1060 | 0.180 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 5 | 2007 | 34 | 0.180 |
Why?
|
| Dopamine Agents | 4 | 1998 | 189 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 678 | 0.180 |
Why?
|
| Biomedical Research | 2 | 2015 | 3429 | 0.180 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2002 | 280 | 0.180 |
Why?
|
| Acetylcholinesterase | 2 | 2013 | 156 | 0.180 |
Why?
|
| Limbic System | 5 | 2000 | 419 | 0.180 |
Why?
|
| Diagnostic Imaging | 6 | 2011 | 3530 | 0.180 |
Why?
|
| Microvessels | 1 | 2024 | 577 | 0.180 |
Why?
|
| Gene Frequency | 13 | 2017 | 3606 | 0.180 |
Why?
|
| Myeloid Cells | 2 | 2024 | 823 | 0.180 |
Why?
|
| Dynamins | 2 | 2014 | 139 | 0.180 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 1999 | 13 | 0.170 |
Why?
|
| N-Methylaspartate | 6 | 2003 | 231 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2021 | 461 | 0.170 |
Why?
|
| Plasmids | 4 | 2012 | 2269 | 0.170 |
Why?
|
| Microtubules | 3 | 2017 | 1074 | 0.170 |
Why?
|
| DNA-Binding Proteins | 8 | 2024 | 9610 | 0.170 |
Why?
|
| Lipids | 5 | 2019 | 3341 | 0.170 |
Why?
|
| Nootropic Agents | 1 | 2021 | 157 | 0.170 |
Why?
|
| Retinal Ganglion Cells | 4 | 2012 | 811 | 0.170 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2010 | 188 | 0.170 |
Why?
|
| Cell Communication | 3 | 2023 | 1657 | 0.170 |
Why?
|
| Protein Precursors | 2 | 1996 | 1132 | 0.170 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 650 | 0.170 |
Why?
|
| Actins | 3 | 2014 | 2050 | 0.170 |
Why?
|
| Benzene Derivatives | 4 | 2008 | 53 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2016 | 1741 | 0.170 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1886 | 0.170 |
Why?
|
| Growth Substances | 1 | 2002 | 768 | 0.170 |
Why?
|
| Presenilin-2 | 5 | 2000 | 95 | 0.170 |
Why?
|
| Protease Nexins | 3 | 2009 | 39 | 0.170 |
Why?
|
| Glucosylceramidase | 1 | 2020 | 127 | 0.170 |
Why?
|
| Multigene Family | 3 | 2015 | 1076 | 0.170 |
Why?
|
| Antigens, CD | 5 | 2011 | 4001 | 0.160 |
Why?
|
| Sensitivity and Specificity | 9 | 2013 | 14666 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2022 | 632 | 0.160 |
Why?
|
| Receptors, CCR5 | 2 | 1998 | 486 | 0.160 |
Why?
|
| Cell Cycle Proteins | 5 | 2011 | 3449 | 0.160 |
Why?
|
| Memory | 10 | 2020 | 2193 | 0.160 |
Why?
|
| Cytokines | 4 | 2018 | 7396 | 0.160 |
Why?
|
| Lipoproteins, VLDL | 2 | 1998 | 201 | 0.160 |
Why?
|
| Artifacts | 1 | 2008 | 1911 | 0.160 |
Why?
|
| Reproducibility of Results | 12 | 2022 | 20099 | 0.160 |
Why?
|
| Apolipoproteins | 2 | 1998 | 326 | 0.160 |
Why?
|
| Sequence Analysis, Protein | 2 | 2018 | 261 | 0.160 |
Why?
|
| Drugs, Investigational | 1 | 2021 | 212 | 0.160 |
Why?
|
| Receptors, Glutamate | 3 | 2001 | 228 | 0.160 |
Why?
|
| Up-Regulation | 6 | 2008 | 4124 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 655 | 0.160 |
Why?
|
| Quantitative Trait Loci | 3 | 2022 | 2116 | 0.160 |
Why?
|
| Structure-Activity Relationship | 10 | 2013 | 3076 | 0.160 |
Why?
|
| Clusterin | 3 | 2014 | 71 | 0.160 |
Why?
|
| Zinc Fingers | 1 | 2021 | 579 | 0.160 |
Why?
|
| Amino Acid Motifs | 5 | 2010 | 931 | 0.160 |
Why?
|
| Plant Proteins | 1 | 2001 | 370 | 0.160 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2017 | 803 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2015 | 2571 | 0.160 |
Why?
|
| Synaptosomes | 1 | 2018 | 116 | 0.150 |
Why?
|
| Stilbenes | 4 | 2008 | 155 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 3 | 2004 | 1486 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2017 | 2468 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3359 | 0.150 |
Why?
|
| Second Messenger Systems | 1 | 2019 | 202 | 0.150 |
Why?
|
| Lipoproteins | 4 | 1998 | 881 | 0.150 |
Why?
|
| Presenilins | 4 | 2019 | 53 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2015 | 1135 | 0.150 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.150 |
Why?
|
| Brain Diseases | 4 | 2018 | 1545 | 0.150 |
Why?
|
| Fibroblasts | 7 | 2018 | 4141 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 256 | 0.150 |
Why?
|
| Amino Acid Sequence | 11 | 2018 | 13446 | 0.150 |
Why?
|
| Membrane Lipids | 2 | 2018 | 252 | 0.150 |
Why?
|
| Oligonucleotide Probes | 5 | 1998 | 416 | 0.150 |
Why?
|
| Immunotherapy | 3 | 2004 | 4652 | 0.150 |
Why?
|
| Amino Acid Substitution | 5 | 2005 | 1739 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2273 | 0.150 |
Why?
|
| Models, Molecular | 4 | 2013 | 5439 | 0.150 |
Why?
|
| Cerebral Veins | 2 | 2001 | 157 | 0.150 |
Why?
|
| DNA Transposable Elements | 1 | 2021 | 755 | 0.150 |
Why?
|
| Metabolome | 1 | 2024 | 989 | 0.150 |
Why?
|
| NADPH Dehydrogenase | 3 | 1994 | 44 | 0.150 |
Why?
|
| Vaccination | 1 | 2010 | 3384 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4176 | 0.150 |
Why?
|
| DNA Primers | 7 | 2011 | 2819 | 0.150 |
Why?
|
| Algorithms | 8 | 2022 | 14032 | 0.140 |
Why?
|
| Craniotomy | 3 | 2010 | 741 | 0.140 |
Why?
|
| Exosomes | 3 | 2018 | 424 | 0.140 |
Why?
|
| Mice, Knockout | 17 | 2018 | 14416 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2012 | 1076 | 0.140 |
Why?
|
| Genetic Linkage | 7 | 2007 | 2341 | 0.140 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 666 | 0.140 |
Why?
|
| Dimerization | 5 | 2006 | 891 | 0.140 |
Why?
|
| Transcriptional Activation | 6 | 2018 | 1756 | 0.140 |
Why?
|
| Neurobehavioral Manifestations | 1 | 1996 | 10 | 0.140 |
Why?
|
| Radiopharmaceuticals | 4 | 2017 | 2651 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 131 | 0.140 |
Why?
|
| Brain Injuries | 2 | 1999 | 2053 | 0.140 |
Why?
|
| Parietal Lobe | 3 | 2021 | 852 | 0.140 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2021 | 301 | 0.140 |
Why?
|
| Blood Vessels | 3 | 2018 | 1113 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2008 | 2885 | 0.140 |
Why?
|
| Microcirculation | 2 | 2001 | 1272 | 0.140 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 2 | 2012 | 29 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1999 | 3612 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 732 | 0.140 |
Why?
|
| Cathepsin D | 2 | 2010 | 59 | 0.140 |
Why?
|
| Superoxide Dismutase | 3 | 2011 | 594 | 0.130 |
Why?
|
| Glycogen Synthase | 1 | 1996 | 62 | 0.130 |
Why?
|
| Neostriatum | 1 | 2017 | 247 | 0.130 |
Why?
|
| Microscopy, Electron | 6 | 2013 | 2561 | 0.130 |
Why?
|
| Autoradiography | 5 | 2017 | 728 | 0.130 |
Why?
|
| Evoked Potentials, Visual | 1 | 2019 | 417 | 0.130 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 915 | 0.130 |
Why?
|
| Mermithoidea | 1 | 2015 | 2 | 0.130 |
Why?
|
| Interferon-beta | 1 | 2018 | 345 | 0.130 |
Why?
|
| Inflammation | 8 | 2020 | 10773 | 0.130 |
Why?
|
| Propionates | 2 | 1993 | 183 | 0.130 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 243 | 0.130 |
Why?
|
| Cerebral Arteries | 2 | 1998 | 490 | 0.130 |
Why?
|
| Movement Disorders | 2 | 2014 | 459 | 0.130 |
Why?
|
| Voluntary Health Agencies | 1 | 2015 | 38 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 7 | 2010 | 1705 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2010 | 602 | 0.130 |
Why?
|
| Protein Structure, Secondary | 4 | 2016 | 1229 | 0.130 |
Why?
|
| Primates | 1 | 1998 | 523 | 0.130 |
Why?
|
| Neuropeptides | 3 | 1998 | 944 | 0.130 |
Why?
|
| Caspase 6 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Epitopes | 4 | 2017 | 2503 | 0.130 |
Why?
|
| Guanosine Triphosphate | 2 | 2014 | 316 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 411 | 0.130 |
Why?
|
| Exocytosis | 1 | 2017 | 320 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 1983 | 540 | 0.130 |
Why?
|
| Macrophage-1 Antigen | 2 | 2006 | 285 | 0.130 |
Why?
|
| Cystatins | 2 | 2008 | 55 | 0.120 |
Why?
|
| Culicidae | 1 | 2015 | 108 | 0.120 |
Why?
|
| Risk Factors | 27 | 2018 | 74213 | 0.120 |
Why?
|
| Caspase 1 | 2 | 2015 | 225 | 0.120 |
Why?
|
| Guidelines as Topic | 2 | 2018 | 1386 | 0.120 |
Why?
|
| Caffeine | 1 | 2020 | 700 | 0.120 |
Why?
|
| Methionine | 2 | 2010 | 572 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2021 | 6241 | 0.120 |
Why?
|
| Ubiquitination | 3 | 2020 | 1007 | 0.120 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1996 | 175 | 0.120 |
Why?
|
| Indoles | 4 | 2011 | 1833 | 0.120 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2009 | 424 | 0.120 |
Why?
|
| Predictive Value of Tests | 16 | 2017 | 15266 | 0.120 |
Why?
|
| Energy Metabolism | 6 | 2020 | 2882 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 694 | 0.120 |
Why?
|
| Metformin | 1 | 2022 | 906 | 0.120 |
Why?
|
| Detergents | 4 | 2012 | 236 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2004 | 477 | 0.120 |
Why?
|
| Aminopyridines | 1 | 2018 | 573 | 0.120 |
Why?
|
| Chemokines | 1 | 1999 | 959 | 0.120 |
Why?
|
| Cloning, Molecular | 3 | 2018 | 4174 | 0.120 |
Why?
|
| Maze Learning | 6 | 2016 | 483 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 78 | 0.120 |
Why?
|
| Formates | 2 | 2021 | 40 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2001 | 1492 | 0.120 |
Why?
|
| Protease Inhibitors | 3 | 2003 | 754 | 0.120 |
Why?
|
| Chemotaxis | 2 | 2013 | 598 | 0.120 |
Why?
|
| Valine | 3 | 2010 | 408 | 0.120 |
Why?
|
| Dermoscopy | 1 | 2014 | 66 | 0.120 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1995 | 93 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 1115 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2016 | 324 | 0.110 |
Why?
|
| Proteins | 3 | 2006 | 6032 | 0.110 |
Why?
|
| Homocysteine | 2 | 2009 | 638 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2021 | 1007 | 0.110 |
Why?
|
| Infrared Rays | 3 | 2005 | 247 | 0.110 |
Why?
|
| Mucolipidoses | 1 | 2014 | 82 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 1997 | 696 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 435 | 0.110 |
Why?
|
| Malonates | 1 | 1993 | 43 | 0.110 |
Why?
|
| Cerebral Decortication | 1 | 1993 | 11 | 0.110 |
Why?
|
| Peptidomimetics | 1 | 2013 | 31 | 0.110 |
Why?
|
| Base Pairing | 1 | 2014 | 140 | 0.110 |
Why?
|
| Autophagy | 2 | 2012 | 1326 | 0.110 |
Why?
|
| United States | 16 | 2024 | 72335 | 0.110 |
Why?
|
| Acetylcysteine | 2 | 2015 | 260 | 0.110 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 1902 | 0.110 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1993 | 89 | 0.110 |
Why?
|
| Prescription Drugs | 1 | 2021 | 631 | 0.110 |
Why?
|
| Uric Acid | 1 | 2020 | 807 | 0.110 |
Why?
|
| Antioxidants | 4 | 2015 | 1668 | 0.110 |
Why?
|
| Diagnosis, Differential | 11 | 2015 | 12975 | 0.110 |
Why?
|
| Quinolines | 3 | 2011 | 764 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 584 | 0.110 |
Why?
|
| Sensation Disorders | 1 | 2014 | 160 | 0.110 |
Why?
|
| Tomography | 2 | 2013 | 411 | 0.110 |
Why?
|
| Sequence Deletion | 3 | 2015 | 1494 | 0.110 |
Why?
|
| Metabolomics | 1 | 2022 | 1659 | 0.110 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1995 | 436 | 0.110 |
Why?
|
| Serine Endopeptidases | 2 | 2009 | 1023 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 371 | 0.110 |
Why?
|
| Enzyme Assays | 1 | 2014 | 104 | 0.110 |
Why?
|
| Microdialysis | 1 | 2013 | 161 | 0.110 |
Why?
|
| Eye | 1 | 2017 | 712 | 0.110 |
Why?
|
| Genetic Variation | 5 | 2018 | 6567 | 0.110 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 2013 | 64 | 0.110 |
Why?
|
| Immunity | 1 | 2019 | 996 | 0.100 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 1996 | 642 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1089 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6019 | 0.100 |
Why?
|
| Peptides | 2 | 2024 | 4358 | 0.100 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 2421 | 0.100 |
Why?
|
| DNA Mutational Analysis | 6 | 2011 | 4111 | 0.100 |
Why?
|
| Surface Plasmon Resonance | 3 | 2008 | 269 | 0.100 |
Why?
|
| Cross-Sectional Studies | 14 | 2021 | 26127 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2018 | 1330 | 0.100 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2012 | 299 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1749 | 0.100 |
Why?
|
| Feedback, Physiological | 3 | 2012 | 476 | 0.100 |
Why?
|
| Nerve Endings | 2 | 1992 | 105 | 0.100 |
Why?
|
| Plant Lectins | 1 | 1992 | 103 | 0.100 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 1992 | 11 | 0.100 |
Why?
|
| Multiprotein Complexes | 3 | 2008 | 1120 | 0.100 |
Why?
|
| Eye Enucleation | 1 | 2012 | 128 | 0.100 |
Why?
|
| Patient Preference | 1 | 2020 | 924 | 0.100 |
Why?
|
| Pyrroles | 1 | 2018 | 1125 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 753 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2416 | 0.100 |
Why?
|
| Enzyme Precursors | 2 | 2010 | 170 | 0.100 |
Why?
|
| Receptors, AMPA | 2 | 2012 | 336 | 0.100 |
Why?
|
| Geriatrics | 1 | 1996 | 388 | 0.100 |
Why?
|
| Quality Control | 2 | 2013 | 832 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 4 | 2011 | 2656 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 117 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 495 | 0.100 |
Why?
|
| Octoxynol | 3 | 2006 | 77 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1265 | 0.100 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2009 | 263 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 307 | 0.100 |
Why?
|
| Laboratories, Hospital | 1 | 2013 | 192 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 296 | 0.100 |
Why?
|
| Homeostasis | 3 | 2013 | 3323 | 0.100 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Membrane Microdomains | 2 | 2010 | 206 | 0.100 |
Why?
|
| Eye Neoplasms | 3 | 1983 | 307 | 0.100 |
Why?
|
| Doxycycline | 2 | 2011 | 344 | 0.100 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3548 | 0.090 |
Why?
|
| Gyrus Cinguli | 1 | 2017 | 1115 | 0.090 |
Why?
|
| Precipitin Tests | 5 | 2004 | 813 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2803 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2811 | 0.090 |
Why?
|
| Microtomy | 1 | 2010 | 44 | 0.090 |
Why?
|
| Chemokine CCL4 | 3 | 2000 | 126 | 0.090 |
Why?
|
| COS Cells | 6 | 2014 | 1130 | 0.090 |
Why?
|
| Antigens | 3 | 1991 | 1443 | 0.090 |
Why?
|
| Macrolides | 1 | 2012 | 205 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2018 | 436 | 0.090 |
Why?
|
| Laser-Doppler Flowmetry | 2 | 2008 | 239 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 5 | 2014 | 370 | 0.090 |
Why?
|
| Aphasia | 2 | 1990 | 192 | 0.090 |
Why?
|
| Retinoblastoma | 3 | 1983 | 317 | 0.090 |
Why?
|
| Proteomics | 2 | 2021 | 3848 | 0.090 |
Why?
|
| Fluoresceins | 1 | 2011 | 235 | 0.090 |
Why?
|
| Photobleaching | 1 | 2010 | 29 | 0.090 |
Why?
|
| Adult | 34 | 2024 | 221203 | 0.090 |
Why?
|
| Radioisotopes | 1 | 2012 | 499 | 0.090 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2001 | 121 | 0.090 |
Why?
|
| Amygdala | 4 | 1992 | 1354 | 0.090 |
Why?
|
| Neural Conduction | 1 | 2012 | 441 | 0.090 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Mutant Proteins | 3 | 2018 | 491 | 0.090 |
Why?
|
| Nevus, Pigmented | 1 | 1992 | 222 | 0.090 |
Why?
|
| Research Design | 3 | 2017 | 6180 | 0.090 |
Why?
|
| Molecular Imaging | 2 | 2014 | 815 | 0.090 |
Why?
|
| Drug Design | 3 | 2011 | 1048 | 0.090 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 3826 | 0.090 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 284 | 0.090 |
Why?
|
| Virus Replication | 1 | 2018 | 2435 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2011 | 197 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2012 | 2358 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2015 | 526 | 0.080 |
Why?
|
| Glycoproteins | 3 | 2012 | 2203 | 0.080 |
Why?
|
| Sweden | 5 | 2015 | 1379 | 0.080 |
Why?
|
| Oligodendroglia | 1 | 2014 | 538 | 0.080 |
Why?
|
| Propidium | 1 | 2009 | 42 | 0.080 |
Why?
|
| Drug Repositioning | 2 | 2022 | 233 | 0.080 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 283 | 0.080 |
Why?
|
| Salicylates | 1 | 2010 | 127 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 2 | 2016 | 1943 | 0.080 |
Why?
|
| Central Nervous System Agents | 1 | 2010 | 75 | 0.080 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2226 | 0.080 |
Why?
|
| DNA | 6 | 2022 | 7213 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2004 | 473 | 0.080 |
Why?
|
| Brain Mapping | 6 | 2016 | 6635 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2009 | 344 | 0.080 |
Why?
|
| Massachusetts | 4 | 2015 | 8830 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2018 | 2556 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1459 | 0.080 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 89 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 999 | 0.080 |
Why?
|
| Optic Nerve | 1 | 2012 | 572 | 0.080 |
Why?
|
| Molecular Biology | 2 | 2007 | 576 | 0.080 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 105 | 0.080 |
Why?
|
| Glucose | 2 | 2016 | 4346 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2012 | 1218 | 0.080 |
Why?
|
| Social Participation | 2 | 2021 | 183 | 0.080 |
Why?
|
| Serum Amyloid A Protein | 1 | 2009 | 127 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2448 | 0.080 |
Why?
|
| Benzoquinones | 2 | 2010 | 198 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 3 | 2016 | 317 | 0.080 |
Why?
|
| Cholecalciferol | 1 | 2013 | 553 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2012 | 413 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2004 | 1141 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2008 | 128 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2022 | 4399 | 0.080 |
Why?
|
| Pyramidal Cells | 2 | 2004 | 369 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 110 | 0.080 |
Why?
|
| Environment | 2 | 2011 | 1123 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| Hydrazines | 1 | 2009 | 224 | 0.070 |
Why?
|
| F2-Isoprostanes | 1 | 2007 | 35 | 0.070 |
Why?
|
| Neural Inhibition | 1 | 2012 | 590 | 0.070 |
Why?
|
| Kinetics | 9 | 2006 | 6374 | 0.070 |
Why?
|
| Neurology | 1 | 1996 | 780 | 0.070 |
Why?
|
| Simvastatin | 1 | 2010 | 346 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2000 | 448 | 0.070 |
Why?
|
| Furans | 2 | 2007 | 202 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2009 | 2112 | 0.070 |
Why?
|
| Nuclear Envelope | 1 | 2008 | 163 | 0.070 |
Why?
|
| Interview, Psychological | 1 | 2011 | 809 | 0.070 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 353 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 1265 | 0.070 |
Why?
|
| Histocytochemistry | 4 | 1998 | 698 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2015 | 868 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 814 | 0.070 |
Why?
|
| Encephalitis | 2 | 2021 | 438 | 0.070 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 369 | 0.070 |
Why?
|
| Microfluidics | 1 | 2013 | 653 | 0.070 |
Why?
|
| Sensation | 1 | 1989 | 337 | 0.070 |
Why?
|
| Receptors, Angiotensin | 1 | 2007 | 141 | 0.070 |
Why?
|
| Leukotrienes | 1 | 2008 | 231 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 2 | 2021 | 421 | 0.070 |
Why?
|
| Cerebellum | 5 | 2006 | 1501 | 0.070 |
Why?
|
| Lactams, Macrocyclic | 2 | 2010 | 318 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 783 | 0.070 |
Why?
|
| Neurofilament Proteins | 2 | 2021 | 336 | 0.070 |
Why?
|
| Lasers | 3 | 2006 | 952 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2006 | 277 | 0.070 |
Why?
|
| Insulysin | 1 | 2007 | 49 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2017 | 3066 | 0.070 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2006 | 24 | 0.070 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2008 | 133 | 0.070 |
Why?
|
| Heparitin Sulfate | 1 | 2008 | 223 | 0.070 |
Why?
|
| Oxidation-Reduction | 4 | 2005 | 2231 | 0.070 |
Why?
|
| Genomics | 2 | 2022 | 5821 | 0.070 |
Why?
|
| Macaca mulatta | 5 | 2004 | 2329 | 0.070 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 513 | 0.070 |
Why?
|
| Myelin Sheath | 2 | 2014 | 653 | 0.070 |
Why?
|
| Drosophila | 3 | 2021 | 1495 | 0.070 |
Why?
|
| t-Complex Genome Region | 1 | 2006 | 5 | 0.070 |
Why?
|
| Auxilins | 1 | 2006 | 29 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2002 | 613 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2013 | 445 | 0.070 |
Why?
|
| Protein Kinases | 1 | 1994 | 1608 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 2 | 2001 | 551 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 12148 | 0.070 |
Why?
|
| Genetic Testing | 5 | 2019 | 3537 | 0.070 |
Why?
|
| Acute Disease | 2 | 2012 | 7237 | 0.070 |
Why?
|
| MPTP Poisoning | 2 | 1998 | 37 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2010 | 633 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 453 | 0.070 |
Why?
|
| Curcumin | 1 | 2007 | 98 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2007 | 277 | 0.070 |
Why?
|
| Toes | 1 | 1987 | 209 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2014 | 695 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2009 | 554 | 0.070 |
Why?
|
| Glutamates | 1 | 1987 | 389 | 0.070 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 2 | 2004 | 17 | 0.060 |
Why?
|
| Regression Analysis | 4 | 2015 | 6344 | 0.060 |
Why?
|
| Delirium | 1 | 2017 | 1668 | 0.060 |
Why?
|
| Mammals | 2 | 2021 | 1132 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2005 | 83 | 0.060 |
Why?
|
| Luminescent Agents | 1 | 2005 | 29 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2018 | 4217 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 5 | 2002 | 413 | 0.060 |
Why?
|
| Patient Care | 1 | 2011 | 622 | 0.060 |
Why?
|
| Half-Life | 1 | 2006 | 651 | 0.060 |
Why?
|
| Linear Models | 4 | 2017 | 5872 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2021 | 8481 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2012 | 874 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 3430 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2004 | 287 | 0.060 |
Why?
|
| Resilience, Psychological | 1 | 2013 | 788 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2008 | 720 | 0.060 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 1519 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2009 | 624 | 0.060 |
Why?
|
| Meninges | 3 | 2006 | 198 | 0.060 |
Why?
|
| Computational Biology | 3 | 2024 | 3517 | 0.060 |
Why?
|
| Glaucoma | 2 | 2017 | 1185 | 0.060 |
Why?
|
| Biophysics | 3 | 2003 | 380 | 0.060 |
Why?
|
| Kidney | 5 | 2006 | 7047 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1406 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 983 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2009 | 829 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 1997 | 420 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 2019 | 2639 | 0.060 |
Why?
|
| Polyneuropathies | 1 | 1986 | 137 | 0.060 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2024 | 9 | 0.060 |
Why?
|
| Anterior Horn Cells | 1 | 2004 | 18 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2009 | 1085 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2696 | 0.060 |
Why?
|
| Steroid Hydroxylases | 1 | 2004 | 93 | 0.060 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 293 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2007 | 849 | 0.060 |
Why?
|
| Sirtuins | 1 | 2007 | 320 | 0.060 |
Why?
|
| Prostaglandins | 2 | 1982 | 398 | 0.060 |
Why?
|
| Substance P | 3 | 1994 | 335 | 0.060 |
Why?
|
| Education, Medical | 1 | 1996 | 1725 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2005 | 1791 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 457 | 0.060 |
Why?
|
| Phagocytosis | 2 | 2016 | 1528 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 903 | 0.060 |
Why?
|
| Annexins | 1 | 2003 | 38 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2006 | 847 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2850 | 0.060 |
Why?
|
| Leukotriene C4 | 1 | 2004 | 79 | 0.060 |
Why?
|
| Annexin A1 | 1 | 2003 | 21 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2004 | 97 | 0.060 |
Why?
|
| Sarcolemma | 1 | 2003 | 65 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1388 | 0.060 |
Why?
|
| Embolism | 1 | 1987 | 399 | 0.060 |
Why?
|
| Stathmin | 1 | 2024 | 70 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2003 | 150 | 0.060 |
Why?
|
| Threonine | 1 | 2004 | 271 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2003 | 44 | 0.060 |
Why?
|
| Denervation | 2 | 1995 | 265 | 0.060 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2192 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2017 | 5079 | 0.050 |
Why?
|
| Glycosylation | 1 | 2006 | 1097 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2003 | 328 | 0.050 |
Why?
|
| Somatostatin | 3 | 1994 | 447 | 0.050 |
Why?
|
| Choline | 2 | 2002 | 515 | 0.050 |
Why?
|
| Putamen | 1 | 2024 | 292 | 0.050 |
Why?
|
| Radioligand Assay | 3 | 2017 | 366 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2005 | 1232 | 0.050 |
Why?
|
| Solitary Nucleus | 1 | 2023 | 54 | 0.050 |
Why?
|
| Naltrexone | 1 | 1985 | 317 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2006 | 559 | 0.050 |
Why?
|
| Prognosis | 6 | 2023 | 29629 | 0.050 |
Why?
|
| Sleep | 1 | 2019 | 4768 | 0.050 |
Why?
|
| Acetylation | 2 | 2021 | 1055 | 0.050 |
Why?
|
| Protein Stability | 2 | 2018 | 578 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 178 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2002 | 1058 | 0.050 |
Why?
|
| Proportional Hazards Models | 6 | 2017 | 12463 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2024 | 390 | 0.050 |
Why?
|
| Fluorescein | 1 | 2003 | 175 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5790 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 1986 | 350 | 0.050 |
Why?
|
| Cadaver | 2 | 2015 | 1358 | 0.050 |
Why?
|
| Dentate Gyrus | 2 | 2021 | 164 | 0.050 |
Why?
|
| Action Potentials | 2 | 2019 | 1834 | 0.050 |
Why?
|
| Cytosol | 1 | 2006 | 888 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 412 | 0.050 |
Why?
|
| Dissection | 1 | 2024 | 298 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2024 | 961 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 574 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2022 | 3769 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2009 | 2665 | 0.050 |
Why?
|
| Syndrome | 4 | 2003 | 3267 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 154 | 0.050 |
Why?
|
| RNA Interference | 3 | 2009 | 2832 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 1992 | 2644 | 0.050 |
Why?
|
| Receptors, CCR3 | 2 | 1998 | 62 | 0.050 |
Why?
|
| Animals, Newborn | 5 | 2006 | 2677 | 0.050 |
Why?
|
| Odds Ratio | 4 | 2017 | 9646 | 0.050 |
Why?
|
| Immunization | 1 | 2006 | 1227 | 0.050 |
Why?
|
| Quinolinic Acids | 2 | 1991 | 15 | 0.050 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2001 | 28 | 0.050 |
Why?
|
| Prefrontal Cortex | 2 | 2023 | 2220 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1866 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1403 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2023 | 302 | 0.050 |
Why?
|
| Chemokine CXCL1 | 1 | 2002 | 101 | 0.050 |
Why?
|
| DNA, Recombinant | 2 | 2006 | 455 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1981 | 64 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2002 | 112 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2018 | 6845 | 0.050 |
Why?
|
| Organ Size | 3 | 2017 | 2254 | 0.050 |
Why?
|
| Models, Biological | 7 | 2012 | 9469 | 0.050 |
Why?
|
| Telomere | 1 | 2008 | 943 | 0.050 |
Why?
|
| Proxy | 1 | 2022 | 151 | 0.050 |
Why?
|
| Vasodilation | 2 | 2007 | 962 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 976 | 0.050 |
Why?
|
| Trypsin Inhibitors | 1 | 2001 | 34 | 0.050 |
Why?
|
| Adamantane | 1 | 2022 | 148 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 561 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2023 | 358 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2021 | 73 | 0.050 |
Why?
|
| Peroxidase | 1 | 2004 | 609 | 0.050 |
Why?
|
| Iron | 1 | 2009 | 1793 | 0.050 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 12059 | 0.050 |
Why?
|
| Photography | 1 | 2024 | 532 | 0.050 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 3 | 1998 | 63 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 411 | 0.050 |
Why?
|
| Thiophenes | 1 | 2005 | 569 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2012 | 9319 | 0.050 |
Why?
|
| Homovanillic Acid | 3 | 1998 | 75 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2022 | 219 | 0.050 |
Why?
|
| Leupeptins | 1 | 2001 | 113 | 0.050 |
Why?
|
| Isoleucine | 2 | 1998 | 110 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1090 | 0.050 |
Why?
|
| Dextrans | 1 | 2003 | 574 | 0.050 |
Why?
|
| Nitroprusside | 1 | 2001 | 272 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10448 | 0.050 |
Why?
|
| Phospholipids | 5 | 1983 | 786 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 333 | 0.050 |
Why?
|
| Dipeptides | 1 | 2002 | 391 | 0.040 |
Why?
|
| Lactates | 4 | 1994 | 405 | 0.040 |
Why?
|
| Protein Subunits | 3 | 2009 | 943 | 0.040 |
Why?
|
| Nitrates | 1 | 2002 | 263 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2735 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2006 | 618 | 0.040 |
Why?
|
| Receptors, Notch | 3 | 2004 | 743 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2002 | 704 | 0.040 |
Why?
|
| Terminology as Topic | 3 | 2014 | 1530 | 0.040 |
Why?
|
| Brain Ischemia | 2 | 2008 | 3049 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 2020 | 916 | 0.040 |
Why?
|
| Vitamins | 1 | 2009 | 1635 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2000 | 135 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 1164 | 0.040 |
Why?
|
| Stroke | 2 | 2015 | 9758 | 0.040 |
Why?
|
| Nitriles | 1 | 2005 | 971 | 0.040 |
Why?
|
| Prospective Studies | 9 | 2017 | 54426 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2002 | 336 | 0.040 |
Why?
|
| Basal Ganglia Diseases | 2 | 2017 | 145 | 0.040 |
Why?
|
| Receptors, Scavenger | 2 | 2001 | 123 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2002 | 2986 | 0.040 |
Why?
|
| Tritium | 2 | 2017 | 708 | 0.040 |
Why?
|
| Hypercholesterolemia | 2 | 2010 | 1141 | 0.040 |
Why?
|
| Cerebral Infarction | 2 | 2002 | 983 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2002 | 562 | 0.040 |
Why?
|
| Catalytic Domain | 2 | 2013 | 705 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2011 | 1959 | 0.040 |
Why?
|
| Least-Squares Analysis | 2 | 2015 | 369 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 621 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 294 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2001 | 251 | 0.040 |
Why?
|
| Cyclic N-Oxides | 3 | 2009 | 72 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2001 | 242 | 0.040 |
Why?
|
| Cryoprotective Agents | 1 | 2001 | 128 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2767 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2004 | 1202 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2006 | 1509 | 0.040 |
Why?
|
| Biological Transport | 4 | 2016 | 2091 | 0.040 |
Why?
|
| Nucleotides | 1 | 2022 | 454 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 840 | 0.040 |
Why?
|
| Anesthesia | 1 | 2010 | 1595 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2022 | 481 | 0.040 |
Why?
|
| Spinal Cord Ischemia | 1 | 2000 | 94 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2017 | 80646 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2000 | 238 | 0.040 |
Why?
|
| Fetus | 3 | 2002 | 1863 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2016 | 5247 | 0.040 |
Why?
|
| Fatty Acids | 3 | 1981 | 1808 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2000 | 316 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2019 | 87 | 0.040 |
Why?
|
| Acids | 1 | 1999 | 125 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 5972 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 749 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1736 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2006 | 2141 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2024 | 918 | 0.040 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 39107 | 0.040 |
Why?
|
| Frontal Lobe | 3 | 2008 | 1420 | 0.040 |
Why?
|
| Carcinoma | 1 | 2010 | 2330 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 4615 | 0.040 |
Why?
|
| Oxygen | 2 | 2008 | 4227 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2024 | 870 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2001 | 629 | 0.040 |
Why?
|
| Retina | 2 | 1997 | 2659 | 0.040 |
Why?
|
| Warfarin | 1 | 1987 | 1483 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 84 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2014 | 535 | 0.040 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.040 |
Why?
|
| Neurocytoma | 1 | 1998 | 29 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 1324 | 0.040 |
Why?
|
| Goals | 1 | 2024 | 711 | 0.040 |
Why?
|
| Densitometry | 1 | 1998 | 151 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1998 | 68 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15633 | 0.040 |
Why?
|
| Equipment Design | 1 | 2006 | 3511 | 0.040 |
Why?
|
| Rabbits | 2 | 2002 | 4772 | 0.040 |
Why?
|
| Ginkgo biloba | 2 | 2009 | 27 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2003 | 1154 | 0.040 |
Why?
|
| Cytoskeleton | 2 | 2017 | 1170 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1047 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 3801 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 687 | 0.040 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1998 | 72 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2017 | 54 | 0.040 |
Why?
|
| Logistic Models | 6 | 2008 | 13255 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 720 | 0.040 |
Why?
|
| Sequence Alignment | 4 | 2009 | 2180 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3416 | 0.040 |
Why?
|
| Cations | 1 | 2018 | 238 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 1762 | 0.040 |
Why?
|
| Probability | 2 | 2020 | 2477 | 0.040 |
Why?
|
| Sex Factors | 3 | 2020 | 10553 | 0.040 |
Why?
|
| Bioethics | 1 | 2019 | 117 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 945 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2018 | 253 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2018 | 532 | 0.040 |
Why?
|
| Rodentia | 1 | 1999 | 262 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1997 | 144 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 694 | 0.040 |
Why?
|
| Flavonoids | 2 | 2014 | 445 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2014 | 563 | 0.040 |
Why?
|
| Medical Records | 1 | 2022 | 1408 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2015 | 418 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2001 | 4431 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 791 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 882 | 0.040 |
Why?
|
| Iowa | 1 | 1996 | 104 | 0.030 |
Why?
|
| Serotyping | 2 | 2009 | 325 | 0.030 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 2 | 2008 | 24 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 835 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 1997 | 168 | 0.030 |
Why?
|
| Nitro Compounds | 2 | 1993 | 74 | 0.030 |
Why?
|
| Allosteric Regulation | 2 | 2013 | 426 | 0.030 |
Why?
|
| Transcytosis | 1 | 2016 | 45 | 0.030 |
Why?
|
| Independent Living | 1 | 2021 | 579 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 675 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 1996 | 1176 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9031 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2009 | 107 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 973 | 0.030 |
Why?
|
| Coculture Techniques | 2 | 2010 | 1341 | 0.030 |
Why?
|
| Risperidone | 1 | 1999 | 381 | 0.030 |
Why?
|
| Long-Term Potentiation | 2 | 2013 | 293 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1997 | 826 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2017 | 1998 | 0.030 |
Why?
|
| Complement C1q | 1 | 2016 | 93 | 0.030 |
Why?
|
| Serotonin | 1 | 2021 | 1041 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2001 | 988 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1999 | 852 | 0.030 |
Why?
|
| Cell Size | 1 | 1998 | 624 | 0.030 |
Why?
|
| Neuropeptide Y | 2 | 1994 | 192 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2003 | 1302 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2001 | 1787 | 0.030 |
Why?
|
| Rats, Inbred Strains | 6 | 1992 | 2088 | 0.030 |
Why?
|
| Tropanes | 1 | 2015 | 48 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2015 | 38 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 333 | 0.030 |
Why?
|
| Memantine | 1 | 1996 | 108 | 0.030 |
Why?
|
| Pedigree | 3 | 2015 | 4542 | 0.030 |
Why?
|
| Piperazines | 1 | 2006 | 2523 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1999 | 741 | 0.030 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 211 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 15501 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 1997 | 602 | 0.030 |
Why?
|
| Glucose Transporter Type 3 | 1 | 1995 | 16 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 543 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1997 | 339 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 934 | 0.030 |
Why?
|
| Argentina | 1 | 2015 | 246 | 0.030 |
Why?
|
| Adenosine Triphosphate | 4 | 1994 | 1989 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 269 | 0.030 |
Why?
|
| Biogenic Amines | 1 | 1994 | 53 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 1848 | 0.030 |
Why?
|
| Reaction Time | 1 | 2001 | 2089 | 0.030 |
Why?
|
| Lameness, Animal | 1 | 2014 | 7 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2024 | 2332 | 0.030 |
Why?
|
| Tooth Diseases | 1 | 1995 | 74 | 0.030 |
Why?
|
| Estrogens | 1 | 2001 | 1522 | 0.030 |
Why?
|
| Organ Specificity | 3 | 1996 | 1968 | 0.030 |
Why?
|
| Particle Size | 1 | 1999 | 1648 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5915 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 85 | 0.030 |
Why?
|
| Azides | 1 | 1994 | 118 | 0.030 |
Why?
|
| Visual Perception | 1 | 2003 | 1389 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.030 |
Why?
|
| Prevalence | 3 | 2016 | 15732 | 0.030 |
Why?
|
| Pathology | 1 | 1997 | 270 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2015 | 150 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3617 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 795 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 2872 | 0.030 |
Why?
|
| Vitamin B 12 | 2 | 2009 | 524 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 170 | 0.030 |
Why?
|
| Alanine | 2 | 2009 | 609 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 1995 | 140 | 0.030 |
Why?
|
| Plant Extracts | 2 | 2009 | 498 | 0.030 |
Why?
|
| Drosophila melanogaster | 3 | 2009 | 1712 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 247 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 418 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 508 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1994 | 1624 | 0.030 |
Why?
|
| Melanoma | 1 | 1992 | 5709 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3778 | 0.030 |
Why?
|
| Cystatin C | 2 | 2008 | 270 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 181 | 0.030 |
Why?
|
| Lactic Acid | 3 | 1993 | 1139 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1998 | 775 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1996 | 672 | 0.030 |
Why?
|
| Mitosis | 1 | 1999 | 1188 | 0.030 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 130 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 300 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2022 | 1163 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2010 | 1134 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 1995 | 469 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1699 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2450 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1994 | 208 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 279 | 0.030 |
Why?
|
| Trigeminal Ganglion | 1 | 1994 | 190 | 0.030 |
Why?
|
| Disulfides | 1 | 2015 | 465 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 415 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2013 | 141 | 0.030 |
Why?
|
| Pyridines | 3 | 2015 | 2875 | 0.030 |
Why?
|
| Space Perception | 2 | 2011 | 465 | 0.030 |
Why?
|
| Eating | 1 | 2020 | 1539 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1992 | 5821 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3422 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 284 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1993 | 298 | 0.030 |
Why?
|
| Electron Transport | 1 | 1993 | 210 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 749 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2865 | 0.030 |
Why?
|
| Wound Healing | 1 | 2003 | 2805 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2000 | 1819 | 0.030 |
Why?
|
| Trypan Blue | 1 | 2011 | 22 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 224 | 0.020 |
Why?
|
| Aminooxyacetic Acid | 1 | 1991 | 7 | 0.020 |
Why?
|
| Organelle Size | 1 | 2011 | 6 | 0.020 |
Why?
|
| Hypercalcemia | 1 | 1995 | 423 | 0.020 |
Why?
|
| Molecular Structure | 2 | 2007 | 1880 | 0.020 |
Why?
|
| Japan | 1 | 1996 | 1378 | 0.020 |
Why?
|
| Cerebrovascular Trauma | 1 | 2011 | 22 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3614 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2004 | 1545 | 0.020 |
Why?
|
| Internet | 1 | 2024 | 3093 | 0.020 |
Why?
|
| Quisqualic Acid | 1 | 1991 | 35 | 0.020 |
Why?
|
| Ecosystem | 1 | 2015 | 490 | 0.020 |
Why?
|
| Drug Interactions | 2 | 2007 | 1416 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1994 | 498 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 161 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 1972 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 210 | 0.020 |
Why?
|
| RNA | 2 | 2012 | 2726 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 2008 | 2091 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 182 | 0.020 |
Why?
|
| Macrophages | 1 | 2006 | 5769 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1994 | 641 | 0.020 |
Why?
|
| Risk | 3 | 2014 | 9610 | 0.020 |
Why?
|
| Intravitreal Injections | 1 | 2012 | 385 | 0.020 |
Why?
|
| Causality | 2 | 2008 | 1242 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2011 | 184 | 0.020 |
Why?
|
| Free Radicals | 2 | 2003 | 238 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2010 | 25 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2012 | 200 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1612 | 0.020 |
Why?
|
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 1990 | 4 | 0.020 |
Why?
|
| Reperfusion | 2 | 2002 | 271 | 0.020 |
Why?
|
| Alkaloids | 1 | 2011 | 192 | 0.020 |
Why?
|
| Lectins | 1 | 1992 | 491 | 0.020 |
Why?
|
| Folic Acid | 2 | 2009 | 1323 | 0.020 |
Why?
|
| Stilbamidines | 1 | 2010 | 43 | 0.020 |
Why?
|
| Nitrogen Oxides | 2 | 2003 | 129 | 0.020 |
Why?
|
| Xanthenes | 1 | 2010 | 72 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2003 | 10194 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 605 | 0.020 |
Why?
|
| Injections | 1 | 1993 | 831 | 0.020 |
Why?
|
| Olfactory Mucosa | 1 | 1991 | 101 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2010 | 231 | 0.020 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2002 | 70 | 0.020 |
Why?
|
| Cathelicidins | 1 | 2010 | 80 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 3085 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2011 | 306 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 1992 | 252 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2011 | 2048 | 0.020 |
Why?
|
| Psychophysiology | 1 | 1990 | 136 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 822 | 0.020 |
Why?
|
| Thalamic Nuclei | 1 | 1990 | 111 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2009 | 4021 | 0.020 |
Why?
|
| Ribosomes | 1 | 1993 | 501 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 1996 | 1814 | 0.020 |
Why?
|
| Integrin alpha3beta1 | 1 | 2009 | 53 | 0.020 |
Why?
|
| Allosteric Site | 1 | 2009 | 103 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 199 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1007 | 0.020 |
Why?
|
| Genes | 1 | 1993 | 1823 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2006 | 3088 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 71 | 0.020 |
Why?
|
| Learning | 1 | 1999 | 1740 | 0.020 |
Why?
|
| Trichothecenes | 1 | 2008 | 6 | 0.020 |
Why?
|
| Neurosurgery | 1 | 1996 | 679 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1186 | 0.020 |
Why?
|
| Neurochemistry | 1 | 1989 | 29 | 0.020 |
Why?
|
| Capillaries | 1 | 1992 | 755 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 866 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 390 | 0.020 |
Why?
|
| ROC Curve | 2 | 2012 | 3579 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 148 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2010 | 277 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 389 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 1995 | 598 | 0.020 |
Why?
|
| Decision Making | 1 | 2022 | 3929 | 0.020 |
Why?
|
| Chromans | 1 | 2009 | 117 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 68 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2008 | 108 | 0.020 |
Why?
|
| Syndecan-3 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Face | 1 | 1995 | 1026 | 0.020 |
Why?
|
| Pyridoxine | 1 | 2009 | 108 | 0.020 |
Why?
|
| Monocytes | 1 | 1998 | 2570 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 314 | 0.020 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2008 | 109 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2004 | 6237 | 0.020 |
Why?
|
| Metals | 1 | 2013 | 719 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 368 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2009 | 280 | 0.020 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2008 | 34 | 0.020 |
Why?
|
| Calibration | 1 | 2011 | 818 | 0.020 |
Why?
|
| Glypicans | 1 | 2008 | 33 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 1986 | 5146 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1638 | 0.020 |
Why?
|
| Neuropsychology | 1 | 1989 | 107 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2009 | 659 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 575 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1991 | 564 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 60 | 0.020 |
Why?
|
| K562 Cells | 1 | 2009 | 642 | 0.020 |
Why?
|
| Oxazines | 1 | 2010 | 350 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 898 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1991 | 902 | 0.020 |
Why?
|
| Heat-Shock Proteins, Small | 1 | 2006 | 6 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 586 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 330 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2007 | 95 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2007 | 66 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2008 | 122 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 372 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1745 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 604 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 353 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 153 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2008 | 208 | 0.020 |
Why?
|
| Vibrissae | 1 | 2007 | 116 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2006 | 66 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2000 | 42230 | 0.020 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 2006 | 74 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2009 | 299 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 960 | 0.020 |
Why?
|
| Skin Window Technique | 1 | 2006 | 22 | 0.020 |
Why?
|
| Myeloma Proteins | 1 | 1986 | 71 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 239 | 0.020 |
Why?
|
| Systems Integration | 1 | 2008 | 426 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 1998 | 430 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1664 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 859 | 0.020 |
Why?
|
| Hyperemia | 1 | 2007 | 221 | 0.020 |
Why?
|
| Color | 1 | 1987 | 299 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2007 | 246 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 1541 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2007 | 261 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2006 | 363 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2007 | 517 | 0.020 |
Why?
|
| Losartan | 1 | 2007 | 265 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1986 | 169 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 53 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1999 | 3067 | 0.020 |
Why?
|
| Receptors, Opioid | 1 | 1985 | 145 | 0.020 |
Why?
|
| Clathrin | 1 | 2006 | 257 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1986 | 285 | 0.020 |
Why?
|
| Catalysis | 1 | 2007 | 774 | 0.020 |
Why?
|
| Succinimides | 1 | 2005 | 81 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4811 | 0.020 |
Why?
|
| Phosphoamino Acids | 1 | 2004 | 6 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 1991 | 933 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10090 | 0.020 |
Why?
|
| Levodopa | 1 | 2005 | 221 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 1990 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3492 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 510 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 623 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2007 | 592 | 0.010 |
Why?
|
| Motor Activity | 1 | 2014 | 2715 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4352 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 113 | 0.010 |
Why?
|
| Medicare | 1 | 2022 | 6770 | 0.010 |
Why?
|
| Tomography, Optical | 1 | 2005 | 129 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1742 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2135 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 664 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 2010 | 1294 | 0.010 |
Why?
|
| Chloroquine | 1 | 2005 | 274 | 0.010 |
Why?
|
| Aminoisobutyric Acids | 1 | 2003 | 39 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1370 | 0.010 |
Why?
|
| Esters | 1 | 2005 | 211 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 654 | 0.010 |
Why?
|
| Length of Stay | 1 | 2017 | 6426 | 0.010 |
Why?
|
| Immunoglobulin G | 3 | 2005 | 4544 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1987 | 1496 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 518 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 771 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1937 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 1986 | 248 | 0.010 |
Why?
|
| Registries | 1 | 1999 | 8224 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 2003 | 140 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9326 | 0.010 |
Why?
|
| Adolescent | 5 | 2000 | 88324 | 0.010 |
Why?
|
| Arthritis | 1 | 2008 | 680 | 0.010 |
Why?
|
| Capsid | 1 | 2006 | 435 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 710 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1982 | 80 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2009 | 12341 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 966 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 21017 | 0.010 |
Why?
|
| Cell Division | 2 | 1981 | 4465 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1982 | 166 | 0.010 |
Why?
|
| Molecular Motor Proteins | 1 | 2003 | 106 | 0.010 |
Why?
|
| Calcimycin | 1 | 1982 | 213 | 0.010 |
Why?
|
| Thalamus | 1 | 1989 | 1047 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 2005 | 351 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1987 | 1055 | 0.010 |
Why?
|
| Child | 4 | 2000 | 80156 | 0.010 |
Why?
|
| Psychomotor Performance | 2 | 2002 | 1882 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2003 | 614 | 0.010 |
Why?
|
| Students, Medical | 1 | 1996 | 1936 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 767 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2644 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2006 | 888 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 2002 | 88 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Vitamin E | 1 | 2006 | 872 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1982 | 294 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2002 | 154 | 0.010 |
Why?
|
| Fear | 1 | 2011 | 1477 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2014 | 3424 | 0.010 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2002 | 40 | 0.010 |
Why?
|
| Trachea | 1 | 1988 | 1089 | 0.010 |
Why?
|
| Microsomes | 1 | 1982 | 251 | 0.010 |
Why?
|
| Family Health | 1 | 2007 | 1257 | 0.010 |
Why?
|
| Diet, Atherogenic | 1 | 1981 | 92 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 23996 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2002 | 507 | 0.010 |
Why?
|
| Ouabain | 1 | 1982 | 247 | 0.010 |
Why?
|
| Heymann Nephritis Antigenic Complex | 1 | 2001 | 15 | 0.010 |
Why?
|
| Mathematics | 1 | 2003 | 707 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1981 | 151 | 0.010 |
Why?
|
| Cerebellar Cortex | 1 | 2002 | 107 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 2002 | 230 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1992 | 4915 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 1981 | 74 | 0.010 |
Why?
|
| Glycerides | 1 | 1981 | 67 | 0.010 |
Why?
|
| Quinolinic Acid | 2 | 1991 | 67 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 3839 | 0.010 |
Why?
|
| Movement | 1 | 2008 | 1479 | 0.010 |
Why?
|
| Imidazoles | 1 | 2007 | 1180 | 0.010 |
Why?
|
| Heparin | 1 | 2009 | 1634 | 0.010 |
Why?
|
| Temperature | 1 | 2008 | 2226 | 0.010 |
Why?
|
| Cholinesterases | 1 | 2001 | 32 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2001 | 251 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 275 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1982 | 427 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 2006 | 751 | 0.010 |
Why?
|
| Carbocyanines | 1 | 2001 | 175 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 1068 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 122 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 426 | 0.010 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2000 | 48 | 0.010 |
Why?
|
| HIV-1 | 1 | 1998 | 6863 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2001 | 157 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4740 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 507 | 0.010 |
Why?
|
| Creatine | 1 | 2002 | 427 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2000 | 185 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 1726 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2000 | 190 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2005 | 740 | 0.010 |
Why?
|
| Vitamin A | 1 | 2003 | 613 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2001 | 296 | 0.010 |
Why?
|
| Gelsolin | 1 | 2000 | 189 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 1899 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2004 | 676 | 0.010 |
Why?
|
| Leukocytes | 1 | 2008 | 2026 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1982 | 597 | 0.010 |
Why?
|
| Observer Variation | 1 | 2006 | 2606 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3847 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2000 | 311 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1981 | 393 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1981 | 903 | 0.010 |
Why?
|
| Fatty Acids, Essential | 1 | 1980 | 97 | 0.010 |
Why?
|
| Glycine | 1 | 1983 | 663 | 0.010 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2001 | 195 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2003 | 64684 | 0.010 |
Why?
|
| Mazindol | 1 | 1998 | 13 | 0.010 |
Why?
|
| Caspase 2 | 1 | 1998 | 26 | 0.010 |
Why?
|
| NAD | 1 | 2003 | 614 | 0.010 |
Why?
|
| Isomerism | 1 | 1999 | 197 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2007 | 2612 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1990 | 5485 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3162 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 1804 | 0.010 |
Why?
|
| Fractals | 1 | 1999 | 127 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1999 | 325 | 0.010 |
Why?
|
| Transferrin | 1 | 1999 | 283 | 0.010 |
Why?
|
| Contrast Media | 1 | 2011 | 5311 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 2010 | 0.010 |
Why?
|
| Radiography | 2 | 2005 | 6965 | 0.010 |
Why?
|
| Encephalitis, Viral | 1 | 1998 | 58 | 0.010 |
Why?
|
| Lod Score | 1 | 1998 | 600 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 1394 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 1171 | 0.010 |
Why?
|
| Hydroxyl Radical | 1 | 1997 | 82 | 0.010 |
Why?
|
| Maleic Anhydrides | 1 | 1977 | 8 | 0.010 |
Why?
|
| Diffusion | 1 | 1999 | 814 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1998 | 214 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 6815 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1986 | 1094 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1997 | 203 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1999 | 611 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 1998 | 212 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 260 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 237 | 0.010 |
Why?
|
| Retinal Artery Occlusion | 1 | 1997 | 77 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 1998 | 297 | 0.010 |
Why?
|
| Coenzymes | 1 | 1997 | 102 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1999 | 702 | 0.010 |
Why?
|
| Triglycerides | 1 | 2004 | 2461 | 0.010 |
Why?
|
| Remission Induction | 1 | 2002 | 2397 | 0.010 |
Why?
|
| Surface Properties | 1 | 1999 | 1161 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1990 | 4758 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1977 | 318 | 0.010 |
Why?
|
| Ions | 1 | 1997 | 256 | 0.010 |
Why?
|
| Reference Standards | 1 | 1999 | 1003 | 0.010 |
Why?
|
| Neutrophils | 1 | 2008 | 3767 | 0.010 |
Why?
|
| Virion | 1 | 1998 | 422 | 0.010 |
Why?
|
| Liposomes | 1 | 1980 | 784 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 1977 | 265 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1999 | 1031 | 0.010 |
Why?
|
| Ubiquinone | 1 | 1997 | 183 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.010 |
Why?
|
| Cell Separation | 1 | 2001 | 1720 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1998 | 957 | 0.010 |
Why?
|
| Spin Labels | 1 | 1997 | 337 | 0.010 |
Why?
|
| Antiparkinson Agents | 1 | 1996 | 184 | 0.010 |
Why?
|
| Aprotinin | 1 | 1995 | 94 | 0.010 |
Why?
|
| Sodium Azide | 1 | 1994 | 24 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1996 | 299 | 0.010 |
Why?
|
| Niacinamide | 1 | 1997 | 413 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2007 | 3060 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2638 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8633 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2002 | 1878 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1994 | 223 | 0.010 |
Why?
|
| Vitreous Body | 1 | 1996 | 399 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1977 | 771 | 0.010 |
Why?
|
| Microinjections | 1 | 1994 | 321 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2009 | 4812 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 2414 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1991 | 6937 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1994 | 1310 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 496 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 6597 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1992 | 145 | 0.010 |
Why?
|
| Ion Channels | 1 | 1997 | 1040 | 0.010 |
Why?
|
| Software | 1 | 2006 | 4434 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 9053 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1997 | 852 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 3577 | 0.010 |
Why?
|
| Tissue Embedding | 1 | 1991 | 42 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1998 | 2202 | 0.010 |
Why?
|
| Psychosurgery | 1 | 1991 | 86 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2510 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1982 | 3312 | 0.010 |
Why?
|
| Pokeweed Mitogens | 1 | 1990 | 38 | 0.010 |
Why?
|
| Substantia Innominata | 1 | 1990 | 23 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7407 | 0.010 |
Why?
|
| Phylogeny | 1 | 1997 | 2811 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 951 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 59255 | 0.000 |
Why?
|
| Liver | 1 | 2004 | 7529 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4948 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1994 | 2257 | 0.000 |
Why?
|
| Skin | 1 | 1981 | 4484 | 0.000 |
Why?
|
| Family | 1 | 1998 | 3194 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1990 | 20571 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1977 | 2479 | 0.000 |
Why?
|
| Obesity | 1 | 2008 | 12947 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1990 | 1606 | 0.000 |
Why?
|
| Agar | 1 | 1985 | 51 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1982 | 11530 | 0.000 |
Why?
|
| Tetanus Toxin | 1 | 1985 | 46 | 0.000 |
Why?
|
| Mucins | 1 | 1988 | 568 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1990 | 1526 | 0.000 |
Why?
|
| Tetanus Toxoid | 1 | 1985 | 189 | 0.000 |
Why?
|
| Epithelium | 1 | 1988 | 1603 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1990 | 1889 | 0.000 |
Why?
|
| Infant | 2 | 2000 | 36192 | 0.000 |
Why?
|
| Immunization, Secondary | 1 | 1985 | 367 | 0.000 |
Why?
|
| Migraine Disorders | 1 | 1994 | 1703 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1990 | 2413 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 26198 | 0.000 |
Why?
|
| Depression | 1 | 1998 | 8124 | 0.000 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1977 | 91 | 0.000 |
Why?
|
| Acylation | 1 | 1977 | 96 | 0.000 |
Why?
|
| Pregnancy | 1 | 1998 | 29876 | 0.000 |
Why?
|
| Adenosine Diphosphate | 1 | 1977 | 422 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1988 | 3677 | 0.000 |
Why?
|
| Epinephrine | 1 | 1977 | 792 | 0.000 |
Why?
|
| HIV Infections | 1 | 1998 | 17352 | 0.000 |
Why?
|
| Aspirin | 1 | 1977 | 3133 | 0.000 |
Why?
|